According to Zhitong Finance App, Changfeng Pharmaceutical (02652.HK) issued an announcement. On July 31, 2026, the company appointed placement agents to induce no less than 6 undertakers to subscribe for 21.7477 million new H shares at an placement price of HK$13.82 per H share in accordance with the terms and conditions of the placement agreement. Placed shares are equivalent to about 7.23% of the issued H shares and about 5.30% of the total number of issued shares, and about 6.74% of the issued H shares and about 5.03% of the total number of issued shares expanded due to the allocation and issuance of the placed shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.